Inhibition of alpha-oxoglutarate and pyruvate oxidation by alpha-oxoderivatives of leucine and valine in rat tissues.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002208:Caproates / Q000494:pharmacology; D002951:Citrates / Q000378:metabolism; D003065:Coenzyme A; D006801:Humans; D007651:Keto Acids / Q000494:pharmacology*; D007656:Ketoglutaric Acids / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D007930:Leucine / Q000494:pharmacology*; D008293:Malates / Q000378:metabolism; D008375:Maple Syrup Urine Disease / Q000378:metabolism; D008660:Metabolism / Q000187:drug effects; D008928:Mitochondria / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D008931:Mitochondria, Muscle / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011773:Pyruvates / Q000378:metabolism*; D051381:Rats; D014631:Valerates / Q000494:pharmacology; D014633:Valine / Q000494:pharmacology*; D014732:Vibration
D002208:Caproates; D002951:Citrates; D007651:Keto Acids; D007656:Ketoglutaric Acids; D008293:Malates; D011773:Pyruvates; D014631:Valerates; D010088:Oxidoreductases; D007930:Leucine; D014633:Valine; D003065:Coenzyme A